Iodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer Previously Treated With Iodine I 131 That Cannot Be Removed By Surgery
PHASE1
This phase I trial is studying the side effects and best dose of iodine I 1...
Status
Completed
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen.
PHASE3
Patients diagnosed with thyroid cancer are commonly treated with surgery to...
Comparison of the Efficacy and Safety of rhTSH as An Adjunctive Diagnostic Tool in Differentiated Thyroid Cancer Patients Who Had Been Thyroidectomized Vs. Patients Who After Thyroid Hormone Withdrawal
PHASE3
This is A non-blinded trial. Oral radioiodine was given 24 hours after the ...